Melanoma News and Research

Latest Melanoma News and Research

Early detection plays big role in nail melanoma prognosis

Karolina Jasko's nails were usually painted during her senior year of high school, so she didn't notice the black vertical line on her right thumbnail until a nail technician pointed it out - and at the time, she didn't think much of it.

26 Jul 2018

New research highlights value of free skin cancer screening program

While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.

26 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

New research uncovers AEP enzyme's importance to immunity

The importance of the enzyme AEP as a key regulatory of the immune system has been discovered in new research from Newcastle University, UK.

24 Jul 2018

ECU researchers develop world’s first blood test that detects melanoma in its early stages

Edith Cowan University researchers have developed the world’s first blood test capable of detecting melanoma in its early stages, a breakthrough that will save thousands of lives, as well as millions of dollars for the health system.

20 Jul 2018

Regular sunscreen use protects young people from melanoma

A world-first study led by University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely used sunscreen.

19 Jul 2018

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay – sometimes even after treatment has concluded.

19 Jul 2018

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Scientists at Dana-Farber/Brigham and Women's Cancer Center have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood of severe side effects.

19 Jul 2018

Melanoma could soon be detected using a blood test

West Australian researchers from Edith Cowan University have managed to develop a blood test that is capable of diagnosing melanomas before they can spread to other parts of the body. The study titled, “A diagnostic autoantibody signature for primary cutaneous melanoma,” was published in the latest issue of the journal Oncotarget.

18 Jul 2018

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent (Australian, No. 2013301125ZL, Chinese No. 2013800472970) titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction."

17 Jul 2018

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

By artificially activating the brain's reward system, researchers at the Technion-Israel Institute of Technology have dramatically reduced the size of cancerous tumors in mice. The findings were published recently in the journal Nature Communications.

16 Jul 2018

'Skin Cancer, Take A Hike!' program promotes sun safety and skin cancer awareness

Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime.

13 Jul 2018

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Among patients with cutaneous melanoma who had brain metastases (MBM), first-line treatment with a checkpoint inhibitor was associated with a 1.4-fold increase in median overall survival, according to results from a national cohort.

13 Jul 2018

Researchers discover critical link in mapping recurrent mutations of melanoma

A critical link in mapping recurrent mutations of melanoma -- the most serious form of skin cancer in humans -- has been discovered by researchers at Washington State University School of Molecular Biosciences, in collaboration with researchers at Georgia State University.

6 Jul 2018

Study reviews accuracy, benefits, limitations of apps used for skin cancer diagnosis

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.

5 Jul 2018

Sun avoidance may be almost as hazardous to health as cigarette smoking

Available on Amazon, Embrace the Sun, by authors Marc B. Sorenson, Ed.D.and William B. Grant, Ph.D.,claim that sun avoidance may be nearly as hazardous to your health as cigarette smoking!

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Cilia appears to play key role in formation of melanoma

Most cells in the human body have a cilium, a slender cell protuberance that picks up signals from the cell's external environment.

2 Jul 2018

New computational method improves ability to track spread of cancer cells

Princeton researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another.

30 Jun 2018

Melanoma News and Research

Latest Melanoma News and Research

Early detection plays big role in nail melanoma prognosis

New research highlights value of free skin cancer screening program

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

New research uncovers AEP enzyme's importance to immunity

ECU researchers develop world’s first blood test that detects melanoma in its early stages

Regular sunscreen use protects young people from melanoma

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments

Melanoma could soon be detected using a blood test

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

'Skin Cancer, Take A Hike!' program promotes sun safety and skin cancer awareness

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Researchers discover critical link in mapping recurrent mutations of melanoma

Study reviews accuracy, benefits, limitations of apps used for skin cancer diagnosis

Sun avoidance may be almost as hazardous to health as cigarette smoking

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Cilia appears to play key role in formation of melanoma

New computational method improves ability to track spread of cancer cells

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Melanoma News and Research

Latest Melanoma News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in